中国实用口腔科杂志

• 论著 • 上一篇    下一篇

OK-432对人口腔鳞癌细胞系Tca8113和BcaCD885药物敏感性研究

李琰刘鹏鸿   

  1. 山西医科大学汾阳学院口腔系,山西  汾阳  032200
  • 出版日期:2016-11-15 发布日期:2016-12-15
  • 基金资助:

    山西医科大学汾阳学院人才引进科研启动基金(1424)

  • Online:2016-11-15 Published:2016-12-15

摘要:

目的    探讨OK-432对人口腔鳞癌细胞系Tca8113和BcaCD885的药物敏感性。方法    采用四基偶氮唑蓝(MTT)法检测不同剂量OK-432在5个时间点(1、2、3、4、5 d)对Tca8113和BcaCD885的生长抑制作用,计算不同时间点OK-432的半数抑癌率(IC50)和生长抑制率,选择药物作用后第4天观察量效关系。结果    OK-432 能明显抑制Tca8113和BcaCD885细胞的增殖生长,与对照组比较差异有统计学意义(P<0.05),其抑制效应随药物浓度升高而增高。结论    OK-432能显著抑制Tca8113和BcaCD885增殖,对Tca8113的敏感性比BcaCD885强。

关键词: OK-432, 口腔鳞癌系, 敏感性

Abstract:

Objective    To study the cytotoxic effects of OK-432 on the two human oral squamous cell carcinoma Tca8113 and BcaCD885 cell lines. Methods    The inhibitory effects and the 50% inhibition concentration values(IC50)of OK-432 against Tca8113 and BcaCD885 with different drug concentration were evaluated by methyl thiazolyl tetrazolium(MTT). The time-dependent cytotoxic effects of OK-432 were in 1-5 days,and the dose-effect relationship was investigated at the 4th day. Results    OK-432 had high anticancer effects on Tca8113 and BcaCD885,and compared with the control group they were significantly higher(P < 0.05),and the cytotoxic effects were dose-dependent. Conclusion        OK-432 significantly inhibits the proliferation of  Tca8113 and BcaCD885 cell,and the inhibition on Tca8113 is stronger than on BcaCD885.

Key words: OK-432, oral squamous cell carcinoma, cell proliferation